Abstract Body

Natural antisense transcripts (NATs) are a class of RNA molecules transcribed from the opposite strand of a protein-coding gene to regulate gene expression. NATs encoded by viruses, such as Hbz in HTLV-1, have been shown to regulate viral expression. In HIV-1 M group, in vitro experiments have shown that expression of a NAT called Ast (nt6888-9461 in HXB2) promotes the establishment and maintenance of latency through PRC2-induced epigenetic regulation of viral expression. We investigated levels of Ast expression in single infected cells isolated from donors on ART.

PBMCs were obtained from 4 donors in the SCOPE cohort on suppressive ART for a median of 5.5 years (4-19 years) and from 1 donor reinitiating ART following a recent treatment interruption. The samples were tested using the cell-associated RNA and DNA single-genome sequencing (CARD-SGS) assay adapted to measure the fraction of infected cells with Ast RNA spanning nt7497-9237 (nt numbers correspond to HXB2). Antisense RNA in two regions of gag and pol (nt764-2283 and nt1826-3529) were also evaluated. Additionally, a digital PCR approach was used to examine both sense and antisense expression in the region spanning 7497nt-7565nt.

A median of ~5% of infected PBMCs contained the 1.7kb fragment of Ast RNA measured by CARD-SGS. Levels of expression ranged from 1-30 copies per cell. The shorter fragment of Ast RNA within the same region measured using the strand-specific digital RT-PCR approach was detected in a median of 28% of infected PBMCs. Antisense RNA in gag and pol regions was also detected in 4% and 11% of infected cells, respectively when measured by CARD-SGS. A similar fraction of infected cells contained sense env and pol RNA as antisense Ast RNA in most donor samples.

Our findings confirm expression of HIV-1 Ast RNA in donors on ART and indicate that antisense transcripts may span the entire length of the HIV-1 provirus, consistent with in vitro studies. Detection of Ast RNA in unstimulated cells from donors on ART warrants the investigation of its bifunctional role as a coding and a regulatory RNA in vivo. Altering in vivo levels of Ast may represent a new HIV-specific approach to reverse or induce viral latency.